Association of a giant developmental venous anomaly and acute disseminated encephalomyelitis: A case report and

Louis Deprez1, Emilie Lommers2

  • 1Departement of Radiology, CHU de Liège, Belgium.

PubMed

Insights

This study reports the first association between acute disseminated encephalomyelitis (ADEM) and giant developmental venous anomaly (DVA) in myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD). Giant DVAs may create a conducive environment for demyelinating lesions, impacting brain micro-perfusion.

Area of Science:

  • Neuroimmunology
  • Neuroradiology
  • Vascular Neurology

Background:

  • Acute disseminated encephalomyelitis (ADEM) is an immune-mediated demyelinating disease.
  • Developmental venous anomalies (DVAs) are common cerebral vascular malformations.
  • Myelin oligodendrocyte glycoprotein antibody-associated disorder (MOGAD) is a CNS demyelinating disease.

Purpose of the Study:

  • To report the first association between ADEM and a giant DVA in a patient with MOGAD.
  • To investigate the potential role of DVAs in the pathogenesis and imaging findings of MOGAD.

Main Methods:

  • Case report of a young woman with MOGAD presenting with neurological symptoms.
  • Neuroimaging including MRI and perfusion studies to characterize brain lesions and DVA.
  • Follow-up imaging to assess lesion evolution and micro-perfusion changes.

Main Results:

  • The patient presented with headache, bradypsychia, and tetrapyramidal syndrome.
  • Imaging revealed disseminated tumefactive inflammatory lesions, with a large lesion centered on a giant right frontal DVA.
  • Perfusion imaging showed increased blood volume and transit time in the DVA and surrounding tissue, which normalized post-treatment.

Conclusions:

  • Giant DVAs may predispose to or potentiate demyelinating lesions in MOGAD.
  • DVAs can alter local brain micro-perfusion, influencing the evolution of inflammatory demyelinating diseases.
  • This case highlights the potential interaction between vascular anomalies and neuroinflammatory conditions.